Plain-English translation of NCT01492972 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study compares two ways to treat prostate cancer that hasn't spread: proton beam radiation therapy alone, or the same radiation combined with (a hormone treatment that blocks male hormones for 6 months). Researchers want to understand whether adding the hormone treatment helps reduce the chance that cancer will return.
Proton beam radiation is an effective treatment for early-stage prostate cancer, but doctors aren't completely sure whether adding hormone-blocking therapy makes it work better. This trial will help answer that question so future patients get the most effective treatment.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either proton beam radiation alone (28 treatments over several weeks) or the same radiation combined with 6 months of hormone-blocking therapy. You'll need to complete pre-treatment testing and then attend regular appointments for radiation sessions and follow-up care to monitor how you're doing and check for any side effects.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
United States